The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Fideuram Intesa Sanpaolo Private Banking S.P.A. acquired a diverse range of new investment stakes in the US equity market during the fourth quarter. These broad institutional moves spanned critical sectors including technology, healthcare, financial services, and energy. The largest new positions were led by Gilead Sciences at $50.8 million, followed by Autodesk at $42.7 million, and Salesforce at $34.8 million.
Sign in to access this content
Sign InThis institutional expansion comes as tech stocks maintain strong momentum, with Salesforce recently reporting an 11% year-over-year revenue growth in its latest fiscal filing per market data. The investments also reflect confidence in the healthcare sector, coinciding with stabilized cash flows for Gilead Sciences. Compared to peers, Fideuram's activity signals a preference for large-cap companies benefiting from the AI boom and financial recovery, mirroring moves by other major European institutional funds in US markets per market data.
Traders are currently monitoring price levels for these instruments, with ADSK closing at $245.15 and CRM at $288.40 (as of May 19, 2026). Looking ahead, market participants should watch the upcoming US Retail Sales data in the economic calendar, which could impact risk appetite for consumer and tech stocks. Additionally, speeches from Fed officials including Collins and Kashkari remain key catalysts for interest rate expectations and institutional valuations.